<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font26 { font-size : 26; } .font28 { font-size : 28; } .font30 { font-size : 30; }</style>
 <body>
  <p>
   <span class="font30">viral </span>
   <span class="font28">(). </span>
   <span class="font26">â€" </span>
   <span class="font24">virus </span>
   <span class="font23">favipiravir </span>
   <span class="font22">model </span>
   <span class="font21">treatment </span>
   <span class="font20">antiviral </span>
   <span class="font19">drug </span>
   <span class="font18">Ebola </span>
   <span class="font17">infection </span>
   <span class="font17">cell </span>
   <span class="font17">infected </span>
   <span class="font16">efficacy </span>
   <span class="font16">cells </span>
   <span class="font16">peak </span>
   <span class="font15">viremia </span>
   <span class="font15">patients </span>
   <span class="font15">rate </span>
   <span class="font15">immune </span>
   <span class="font15">load </span>
   <span class="font15">concentrations </span>
   <span class="font15">dynamics </span>
   <span class="font15">effect </span>
   <span class="font15">mg/kg </span>
   <span class="font14">response </span>
   <span class="font14">treated </span>
   <span class="font14">animals </span>
   <span class="font14">survival </span>
   <span class="font14">levels </span>
   <span class="font14">target </span>
   <span class="font14">used </span>
   <span class="font14">models </span>
   <span class="font14">{border-style </span>
   <span class="font13">JIKI </span>
   <span class="font13">days </span>
   <span class="font13">infection. </span>
   <span class="font13">results </span>
   <span class="font13">clinical </span>
   <span class="font13">data </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">b.i.d. </span>
   <span class="font13">Figure </span>
   <span class="font13">day </span>
   <span class="font13">doses </span>
   <span class="font13">dosing </span>
   <span class="font13">mice </span>
   <span class="font13">ribavirin </span>
   <span class="font13">acute </span>
   <span class="font13">disease </span>
   <span class="font13">infection, </span>
   <span class="font13">lower </span>
   <span class="font13">obtained </span>
   <span class="font13">trial </span>
   <span class="font12">EBOV </span>
   <span class="font12">Lassa </span>
   <span class="font12">high </span>
   <span class="font12">observed </span>
   <span class="font12">studies </span>
   <span class="font12">untreated </span>
   <span class="font12">Zika </span>
   <span class="font12">cytokine </span>
   <span class="font12">macaques </span>
   <span class="font12">use </span>
   <span class="font12">using </span>
   <span class="font12">EVD </span>
   <span class="font12">associated </span>
   <span class="font12">concentration </span>
   <span class="font12">human </span>
   <span class="font12">influenza </span>
   <span class="font12">modeling </span>
   <span class="font12">predicted </span>
   <span class="font12">time </span>
   <span class="font12">virus, </span>
   <span class="font12">Dis., </span>
   <span class="font12">early </span>
   <span class="font12">fever </span>
   <span class="font12">innate </span>
   <span class="font12">level </span>
   <span class="font12">number </span>
   <span class="font12">regimen </span>
   <span class="font12">(Figure </span>
   <span class="font12">Antiviral </span>
   <span class="font12">Med., </span>
   <span class="font12">achieve </span>
   <span class="font12">adaptive </span>
   <span class="font12">cynomolgus </span>
   <span class="font12">cytokines </span>
   <span class="font12">initiated </span>
   <span class="font12">limited </span>
   <span class="font12">model, </span>
   <span class="font12">plasma </span>
   <span class="font12">reduce </span>
   <span class="font11">Infect. </span>
   <span class="font11">NHP </span>
   <span class="font11">NHPs </span>
   <span class="font11">activity </span>
   <span class="font11">analysis </span>
   <span class="font11">assuming </span>
   <span class="font11">cells, </span>
   <span class="font11">does </span>
   <span class="font11">estimated </span>
   <span class="font11">experiments </span>
   <span class="font11">increase </span>
   <span class="font11">initiation </span>
   <span class="font11">loss </span>
   <span class="font11">nonhuman </span>
   <span class="font11">(.â€".) </span>
   <span class="font11">IFNÎ± </span>
   <span class="font11">Marburg </span>
   <span class="font11">Perelson, </span>
   <span class="font11">Rev. </span>
   <span class="font11">animal </span>
   <span class="font11">close </span>
   <span class="font11">context </span>
   <span class="font11">drugs </span>
   <span class="font11">effective </span>
   <span class="font11">expressing </span>
   <span class="font11">favipiravir, </span>
   <span class="font11">hepatitis </span>
   <span class="font11">including </span>
   <span class="font11">large </span>
   <span class="font11">larger </span>
   <span class="font11">model. </span>
   <span class="font11">particular </span>
   <span class="font11">px; </span>
   <span class="font11">ref. </span>
   <span class="font11">replication </span>
   <span class="font11">similar </span>
   <span class="font11">{font-family </span>
   <span class="font11">Favipiravir </span>
   <span class="font11">Given </span>
   <span class="font11">However, </span>
   <span class="font11">Nat. </span>
   <span class="font11">RNA </span>
   <span class="font11">Res., </span>
   <span class="font11">Thus, </span>
   <span class="font11">chronic </span>
   <span class="font11">compared </span>
   <span class="font11">fact </span>
   <span class="font11">following </span>
   <span class="font11">font-size </span>
   <span class="font11">given </span>
   <span class="font11">kinetics </span>
   <span class="font11">leading </span>
   <span class="font11">mathematical </span>
   <span class="font11">needed </span>
   <span class="font11">outbreak </span>
   <span class="font11">production </span>
   <span class="font11">relevant </span>
   <span class="font11">response, </span>
   <span class="font11">role </span>
   <span class="font11">shown </span>
   <span class="font11">trial, </span>
   <span class="font11">vitro </span>
   <span class="font11">(see </span>
   <span class="font11">Clin. </span>
   <span class="font11">IL, </span>
   <span class="font11">J., </span>
   <span class="font11">Mauritian </span>
   <span class="font11">Viral </span>
   <span class="font11">account </span>
   <span class="font11">achieved </span>
   <span class="font11">action </span>
   <span class="font11">available </span>
   <span class="font11">basic </span>
   <span class="font11">benefit </span>
   <span class="font11">better </span>
   <span class="font11">combination </span>
   <span class="font11">developed </span>
   <span class="font11">development </span>
   <span class="font11">dose </span>
   <span class="font11">double; </span>
   <span class="font11">effectiveness </span>
   <span class="font11">equal </span>
   <span class="font11">exposure </span>
   <span class="font11">favipiravir. </span>
   <span class="font11">growth </span>
   <span class="font11">host </span>
   <span class="font11">humans </span>
   <span class="font11">identify </span>
   <span class="font11">involved </span>
   <span class="font11">maximal </span>
   <span class="font11">models, </span>
   <span class="font11">new </span>
   <span class="font11">noted </span>
   <span class="font11">parameters </span>
   <span class="font11">predictions </span>
   <span class="font11">provided </span>
   <span class="font11">proâ€�inflammatory </span>
   <span class="font11">regimens </span>
   <span class="font11">remain </span>
   <span class="font11">reported </span>
   <span class="font11">significant </span>
   <span class="font11">significantly </span>
   <span class="font11">specific </span>
   <span class="font11">subsequent </span>
   <span class="font11">sufficient </span>
   <span class="font11">suggesting </span>
   <span class="font11">trial. </span>
   <span class="font11">virus; </span>
   <span class="font11">â€"Â </span>
   <span class="font11">(Eq. </span>
   <span class="font11">(i.e., </span>
   <span class="font11">Acad. </span>
   <span class="font11">Biol., </span>
   <span class="font11">EBOV, </span>
   <span class="font11">FAVIPIRAVIR </span>
   <span class="font11">IFNÎ±, </span>
   <span class="font11">Model </span>
   <span class="font11">PKs </span>
   <span class="font11">Proc. </span>
   <span class="font11">absence </span>
   <span class="font11">administered </span>
   <span class="font11">and, </span>
   <span class="font11">approved </span>
   <span class="font11">baseline </span>
   <span class="font11">best </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">capture </span>
   <span class="font11">cells. </span>
   <span class="font11">conducted </span>
   <span class="font11">death, </span>
   <span class="font11">decline </span>
   <span class="font11">delay </span>
   <span class="font11">description </span>
   <span class="font11">different </span>
   <span class="font11">disease. </span>
   <span class="font11">elimination </span>
   <span class="font11">emerging </span>
   <span class="font11">experiment </span>
   <span class="font11">experiments, </span>
   <span class="font11">followed </span>
   <span class="font11">higher </span>
   <span class="font11">included </span>
   <span class="font11">increasing </span>
   <span class="font11">infections </span>
   <span class="font11">infections. </span>
   <span class="font11">kinetic </span>
   <span class="font11">left </span>
   <span class="font11">levels, </span>
   <span class="font11">limiting </span>
   <span class="font11">main </span>
   <span class="font11">median </span>
   <span class="font11">need </span>
   <span class="font11">order </span>
   <span class="font11">parameter </span>
   <span class="font11">polymerase </span>
   <span class="font11">possible </span>
   <span class="font11">primates </span>
   <span class="font11">prophylaxis </span>
   <span class="font11">protection </span>
   <span class="font11">rapid </span>
   <span class="font11">receiving </span>
   <span class="font11">reducing </span>
   <span class="font11">reduction </span>
   <span class="font11">refractory </span>
   <span class="font11">release </span>
   <span class="font11">rhesus </span>
   <span class="font11">set </span>
   <span class="font11">showed </span>
   <span class="font11">solid; </span>
   <span class="font11">survival. </span>
   <span class="font11">therapeutic </span>
   <span class="font11">timing </span>
   <span class="font11">value </span>
   <span class="font11">values </span>
   <span class="font11">viremia, </span>
   <span class="font11">virus. </span>
   <span class="font11">viruses. </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">&amp;gt;Â </span>
   <span class="font10">(NÂ </span>
   <span class="font10">(iii) </span>
   <span class="font10">(nÂ </span>
   <span class="font10">Based </span>
   <span class="font10">Feldmann, </span>
   <span class="font10">Guedj, </span>
   <span class="font10">IFN </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">Lancet, </span>
   <span class="font10">Madelain, </span>
   <span class="font10">Natl. </span>
   <span class="font10">Nature, </span>
   <span class="font10">Pharmacometrics </span>
   <span class="font10">S., </span>
   <span class="font10">S.et </span>
   <span class="font10">Sci. </span>
   <span class="font10">V.et </span>
   <span class="font10">Virol., </span>
   <span class="font10">Warren, </span>
   <span class="font10">Zaire </span>
   <span class="font10">additional </span>
   <span class="font10">alEbola </span>
   <span class="font10">alEfficacy </span>
   <span class="font10">alFavipiravir </span>
   <span class="font10">aldehyde </span>
   <span class="font10">animals, </span>
   <span class="font10">antibodies </span>
   <span class="font10">assumed </span>
   <span class="font10">bold </span>
   <span class="font10">called </span>
   <span class="font10">case </span>
   <span class="font10">cases </span>
   <span class="font10">characterize </span>
   <span class="font10">collected </span>
   <span class="font10">compartments </span>
   <span class="font10">courier; </span>
   <span class="font10">critical </span>
   <span class="font10">cytotoxic </span>
   <span class="font10">delayed </span>
   <span class="font10">dynamic </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">evaluation </span>
   <span class="font10">extended </span>
   <span class="font10">fever. </span>
   <span class="font10">fully </span>
   <span class="font10">halfâ€�life </span>
   <span class="font10">hemorrhagic </span>
   <span class="font10">identified </span>
   <span class="font10">impact </span>
   <span class="font10">instance </span>
   <span class="font10">lymphocyte </span>
   <span class="font10">lymphocytes </span>
   <span class="font10">macaques. </span>
   <span class="font10">modeled </span>
   <span class="font10">monoclonal </span>
   <span class="font10">outbreak, </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">performed </span>
   <span class="font10">postexposure </span>
   <span class="font10">potentiate </span>
   <span class="font10">primate </span>
   <span class="font10">process </span>
   <span class="font10">pt;} </span>
   <span class="font10">reduced </span>
   <span class="font10">reduces </span>
   <span class="font10">review </span>
   <span class="font10">severe </span>
   <span class="font10">small </span>
   <span class="font10">species </span>
   <span class="font10">strong </span>
   <span class="font10">study </span>
   <span class="font10">susceptible </span>
   <span class="font10">terms </span>
   <span class="font10">testing </span>
   <span class="font10">treatment, </span>
   <span class="font10">treatment. </span>
   <span class="font10">trials </span>
   <span class="font10">twice </span>
   <span class="font10">understand </span>
   <span class="font10">various </span>
   <span class="font10">viruses </span>
   <span class="font10">viruses, </span>
   <span class="font10">vivo </span>
   <span class="font10">Âµg/mL, </span>
  </p>
 </body>
</html>
